| Dr Andrew John White, MD | |
|
200 S 5th St Ste A, Salina, KS 67401-3906 | |
| (785) 827-2238 | |
| (785) 827-1684 |
| Full Name | Dr Andrew John White |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 16 Years |
| Location | 200 S 5th St Ste A, Salina, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124287792 | NPI | - | NPPES |
| 200490450A | Medicaid | OK | |
| 201073560A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 04-36267 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salina Regional Health Center | Salina, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Central Kansas Pa | 6406744093 | 26 |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).
A research team at the Faculty of Medicine & Dentistry at the University of Alberta have discovered a new way by which metabolism is linked to the regulation of DNA, the basis of our genetic code. The findings may have important implications for the understanding of many common diseases, including cancer.
An international team of physicists at Los Alamos National Laboratory has succeeded in using intense laser light to accelerate protons to energies never before achieved. Using this technique, scientists can now accelerate particles to extremely high velocities that would otherwise only be possible using large accelerator facilities. Physicists around the world are examining laser particle acceleration and laser produced radiation for potential future uses in cancer treatment.
› Verified 6 days ago
| Entity Name | Anesthesia Associates Of Central Kansas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164494084 PECOS PAC ID: 6406744093 Enrollment ID: O20040121000483 |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).
A research team at the Faculty of Medicine & Dentistry at the University of Alberta have discovered a new way by which metabolism is linked to the regulation of DNA, the basis of our genetic code. The findings may have important implications for the understanding of many common diseases, including cancer.
An international team of physicists at Los Alamos National Laboratory has succeeded in using intense laser light to accelerate protons to energies never before achieved. Using this technique, scientists can now accelerate particles to extremely high velocities that would otherwise only be possible using large accelerator facilities. Physicists around the world are examining laser particle acceleration and laser produced radiation for potential future uses in cancer treatment.
› Verified 6 days ago
| Entity Name | West Central Kansas Association Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1417939729 PECOS PAC ID: 4981512001 Enrollment ID: O20061104000447 |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).
A research team at the Faculty of Medicine & Dentistry at the University of Alberta have discovered a new way by which metabolism is linked to the regulation of DNA, the basis of our genetic code. The findings may have important implications for the understanding of many common diseases, including cancer.
An international team of physicists at Los Alamos National Laboratory has succeeded in using intense laser light to accelerate protons to energies never before achieved. Using this technique, scientists can now accelerate particles to extremely high velocities that would otherwise only be possible using large accelerator facilities. Physicists around the world are examining laser particle acceleration and laser produced radiation for potential future uses in cancer treatment.
› Verified 6 days ago
| Entity Name | Hillsboro Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710525985 PECOS PAC ID: 4587090121 Enrollment ID: O20200407002361 |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).
A research team at the Faculty of Medicine & Dentistry at the University of Alberta have discovered a new way by which metabolism is linked to the regulation of DNA, the basis of our genetic code. The findings may have important implications for the understanding of many common diseases, including cancer.
An international team of physicists at Los Alamos National Laboratory has succeeded in using intense laser light to accelerate protons to energies never before achieved. Using this technique, scientists can now accelerate particles to extremely high velocities that would otherwise only be possible using large accelerator facilities. Physicists around the world are examining laser particle acceleration and laser produced radiation for potential future uses in cancer treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew John White, MD 200 S 5th St Ste A, Salina, KS 67401-3906 Ph: (785) 827-2238 | Dr Andrew John White, MD 200 S 5th St Ste A, Salina, KS 67401-3906 Ph: (785) 827-2238 |
News Archive
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).
A research team at the Faculty of Medicine & Dentistry at the University of Alberta have discovered a new way by which metabolism is linked to the regulation of DNA, the basis of our genetic code. The findings may have important implications for the understanding of many common diseases, including cancer.
An international team of physicists at Los Alamos National Laboratory has succeeded in using intense laser light to accelerate protons to energies never before achieved. Using this technique, scientists can now accelerate particles to extremely high velocities that would otherwise only be possible using large accelerator facilities. Physicists around the world are examining laser particle acceleration and laser produced radiation for potential future uses in cancer treatment.
› Verified 6 days ago